Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.

Shah SC, Naymagon S, Panchal HJ, Sands BE, Cohen BL, Dubinsky MC.

Inflamm Bowel Dis. 2018 Feb 15;24(3):651-659. doi: 10.1093/ibd/izx039.

PMID:
29462380
2.

Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease.

Cohen BL, Sachar DB.

BMJ. 2017 Jun 19;357:j2505. doi: 10.1136/bmj.j2505. Review.

PMID:
28630047
3.

The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.

Hirten R, Sands BE, Cohen BL.

Dig Dis Sci. 2017 May;62(5):1116-1118. doi: 10.1007/s10620-017-4555-5. No abstract available.

PMID:
28365918
4.

Colonic Pseudopolyps Resulting in Iron Deficiency Anemia.

Hirten R, Cohen BL, Colombel JF.

Clin Gastroenterol Hepatol. 2017 May;15(5):A27. doi: 10.1016/j.cgh.2017.01.007. Epub 2017 Jan 19. No abstract available.

PMID:
28110094
5.

There is Significant Practice Pattern Variability in the Management of the Hospitalized Ulcerative Colitis Patient at a Tertiary Care and IBD Referral Center.

Shah SC, Naymagon S, Cohen BL, Sands BE, Dubinsky MC.

J Clin Gastroenterol. 2018 Apr;52(4):333-338. doi: 10.1097/MCG.0000000000000779.

PMID:
28009685
6.

Reply.

Cohen BL, Ha C.

Inflamm Bowel Dis. 2016 Nov;22(11):E41. No abstract available.

PMID:
27618504
7.

State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.

Cohen BL, Ha C, Ananthakrishnan AN, Rieder F, Bewtra M.

Inflamm Bowel Dis. 2016 Jul;22(7):1609-15. doi: 10.1097/MIB.0000000000000766.

8.

Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.

Rieder F, Cohen BL, Dotson JL, Bewtra M, Ananthakrishnan AN, Falaiye TO, Ha CY.

Inflamm Bowel Dis. 2016 Jun;22(6):1531-2. doi: 10.1097/MIB.0000000000000814. No abstract available.

9.

Features of Patients With Crohn's Disease and Hidradenitis Suppurativa.

Kamal N, Cohen BL, Buche S, Delaporte E, Colombel JF.

Clin Gastroenterol Hepatol. 2016 Jan;14(1):71-9. doi: 10.1016/j.cgh.2015.04.180. Epub 2015 May 5.

PMID:
25956836
10.

A review of the impact of biologics on surgical complications in Crohn's disease.

Chang MI, Cohen BL, Greenstein AJ.

Inflamm Bowel Dis. 2015 Jun;21(6):1472-7. doi: 10.1097/MIB.0000000000000362. Review.

11.

High-dose infliximab therapy in Crohn's disease: clinical experience, safety, and efficacy.

Hendler SA, Cohen BL, Colombel JF, Sands BE, Mayer L, Agarwal S.

J Crohns Colitis. 2015 Mar;9(3):266-75. doi: 10.1093/ecco-jcc/jju026. Epub 2014 Dec 24.

PMID:
25540149
12.

Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.

Ho TH, Cohen BL, Colombel JF, Mehandru S.

Aliment Pharmacol Ther. 2014 Nov;40(10):1171-86. doi: 10.1111/apt.12976. Epub 2014 Sep 30. Review.

13.

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity.

Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE.

Aliment Pharmacol Ther. 2014 Apr;39(8):811-22. doi: 10.1111/apt.12659. Epub 2014 Feb 20.

14.

Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.

Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, Cohen BL, Pineton de Chambrun G, Asciutti S, Odin JA, Sachar DB, Gaskins HR, Setchell K, Colombel JF, Itzkowitz SH.

Inflamm Bowel Dis. 2013 Feb;19(2):275-82. doi: 10.1097/MIB.0b013e318286ff2e.

PMID:
23348121
15.

Long-term outcomes and prognostic factors for patients with endoscopy-negative iron deficiency.

Soon A, Cohen BL, Groessl EJ, Ho SB.

Dig Dis Sci. 2013 Feb;58(2):488-95. doi: 10.1007/s10620-012-2368-0. Epub 2012 Sep 4.

16.

Immunosuppression in inflammatory bowel disease: how much is too much?

Cohen BL, Torres J, Colombel JF.

Curr Opin Gastroenterol. 2012 Jul;28(4):341-8. doi: 10.1097/MOG.0b013e328354567f. Review.

PMID:
22573191
17.

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, Cohen BL, Brenner D, Sirlin C, Loomba R; San Diego Integrated NAFLD Research Consortium (SINC).

Hepatology. 2012 Sep;56(3):922-32. doi: 10.1002/hep.25731. Epub 2012 Jul 2.

18.

Letter to the editor: response to EPA position on cancer risk from low level radiation.

Cohen BL.

Dose Response. 2010 Feb 25;8(3):384-6. doi: 10.2203/dose-response.09-046.Cohen. No abstract available.

19.

What is the predictive value of urodynamics to reproduce clinical findings of urinary frequency, urge urinary incontinence, and/or stress urinary incontinence?

Caruso DJ, Kanagarajah P, Cohen BL, Ayyathurai R, Gomez C, Gousse AE.

Int Urogynecol J. 2010 Oct;21(10):1205-9. doi: 10.1007/s00192-010-1180-7. Epub 2010 Jun 18.

PMID:
20559620
20.

Small cell carcinoma of the bladder in transplant recipients: a report of 2 cases.

Katkoori D, Cohen BL, Soloway MS, Manoharan M.

Can Urol Assoc J. 2010 Feb;4(1):E4-6.

21.

Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis.

Xu K, Nieuwenhuis E, Cohen BL, Wang W, Canty AJ, Danska JS, Coultas L, Rossant J, Wu MY, Piscione TD, Nagy A, Gossler A, Hicks GG, Hui CC, Henkelman RM, Yu LX, Sled JG, Gridley T, Egan SE.

Am J Physiol Lung Cell Mol Physiol. 2010 Jan;298(1):L45-56. doi: 10.1152/ajplung.90550.2008. Epub 2009 Nov 6.

22.

Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder.

Cohen BL, Caruso DJ, Kanagarajah P, Gousse AE.

Adv Urol. 2009:328364. doi: 10.1155/2009/328364. Epub 2009 Sep 8.

23.

Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.

Cohen BL, Barboglio P, Rodriguez D, Gousse AE.

Neurourol Urodyn. 2009;28(3):205-8. doi: 10.1002/nau.20611.

PMID:
19058190
24.

Test of the linear-no threshold theory: rationale for procedures.

Cohen BL.

Dose Response. 2006 May 1;3(3):369-90. doi: 10.2203/dose-response.003.03.007.

25.

Publications by students doing a year of full-time research: what are realistic expectations?

Cohen BL, Friedman E, Zier K.

Am J Med. 2008 Jun;121(6):545-8. doi: 10.1016/j.amjmed.2008.03.006. No abstract available.

PMID:
18501238
26.

The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument.

Cohen BL, Barboglio P, Gousse A.

J Sex Med. 2008 Jun;5(6):1418-23. doi: 10.1111/j.1743-6109.2008.00818.x. Epub 2008 Mar 19.

PMID:
18355169
27.

Guido Pontecorvo ("Ponte"): a centenary memoir.

Cohen BL.

Genetics. 2007 Nov;177(3):1439-44. No abstract available.

28.

Current techniques for vesicovaginal fistula repair: surgical pearls to optimize cure rate.

Cohen BL, Gousse AE.

Curr Urol Rep. 2007 Sep;8(5):413-8. Review.

PMID:
17880842
29.

Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.

Cohen BL, Rivera R, Barboglio P, Gousse A.

J Urol. 2007 Mar;177(3):1006-10; discussion 1010.

PMID:
17296397
30.

HAS1 expression in bladder cancer and its relation to urinary HA test.

Golshani R, Hautmann SH, Estrella V, Cohen BL, Kyle CC, Manoharan M, Jorda M, Soloway MS, Lokeshwar VB.

Int J Cancer. 2007 Apr 15;120(8):1712-20.

31.

Understanding the toxicity of buried radioactive waste.

Cohen BL.

Health Phys. 2006 Oct;91(4):394-6. No abstract available.

PMID:
16966886
32.

Predictors of success for first stage neuromodulation: motor versus sensory response.

Cohen BL, Tunuguntla HS, Gousse A.

J Urol. 2006 Jun;175(6):2178-80; discussion 2180-1.

PMID:
16697833
33.

Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence.

Cohen BL, Gomez P, Omori Y, Duncan RC, Civantos F, Soloway MS, Lokeshwar VB, Lokeshwar BL.

Int J Cancer. 2006 Sep 1;119(5):1082-7.

34.

Understanding the toxicity of buried radioactive waste and its impacts.

Cohen BL.

Health Phys. 2005 Oct;89(4):355-8.

PMID:
16155457
35.

Development of a questionnaire to measure quality of life in families with a child with food allergy.

Cohen BL, Noone S, Muñoz-Furlong A, Sicherer SH.

J Allergy Clin Immunol. 2004 Nov;114(5):1159-63.

PMID:
15536425
36.

Racial differences in prostate androgen levels in men with clinically localized prostate cancer.

Mohler JL, Gaston KE, Moore DT, Schell MJ, Cohen BL, Weaver C, Petrusz P.

J Urol. 2004 Jun;171(6 Pt 1):2277-80.

PMID:
15126802
37.

The Van Pelt reassessment of our lung cancer vs. radon study.

Cohen BL.

Health Phys. 2004 Mar;86(3):316-8; author reply 318. No abstract available.

PMID:
14982234
38.

Treatment of shoulder complaints.

Cohen BL.

Lancet. 2004 Feb 7;363(9407):492. No abstract available.

PMID:
14962540
39.

The Puskin observation on smoking as a confounder in ecologic correlations of cancer mortality rates with average county radon levels.

Cohen BL.

Health Phys. 2004 Feb;86(2):203-4; author reply 204-5. No abstract available.

PMID:
14744056
40.
41.

Cancer risk from low-level radiation.

Cohen BL.

AJR Am J Roentgenol. 2002 Nov;179(5):1137-43. Review. No abstract available.

PMID:
12388487
42.

Response to 'The potential for bias in Cohen's ecological analysis of lung cancer and residential radon'.

Cohen BL.

J Radiol Prot. 2002 Sep;22(3):305-7; author reply 307-9. No abstract available.

PMID:
12375791
43.

Why response-mode research loses out.

Cohen BL.

Nature. 2002 Sep 19;419(6904):248. No abstract available.

PMID:
12239541
44.

Phylogenetic relationships of Indian caecilians (Amphibia: Gymnophiona) inferred from mitochondrial rRNA gene sequences.

Wilkinson M, A Sheps J, Oommen OV, Cohen BL.

Mol Phylogenet Evol. 2002 Jun;23(3):401-7.

PMID:
12099794
45.

Archiving molecular phylogenetic alignments as NEXUS files.

Cohen BL, Sheps JA, Wilkinson M.

Syst Biol. 1998 Sep;47(3):495-6. No abstract available.

PMID:
12066689
46.

Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1.

Koch U, Lacombe TA, Holland D, Bowman JL, Cohen BL, Egan SE, Guidos CJ.

Immunity. 2001 Aug;15(2):225-36.

47.

Radon exposure and the risk of lung cancer.

Cohen BL.

J Radiol Prot. 2001 Mar;21(1):64-6. No abstract available.

PMID:
11281533
48.

Re: "Parallel analyses of individual and ecologic data on residential radon, cofactors, and lung cancer in Sweden".

Cohen BL.

Am J Epidemiol. 2000 Jul 15;152(2):194-5. No abstract available.

PMID:
10909958
49.

Explaining the lung cancer versus radon exposure data for USA counties.

Cohen BL.

J Radiol Prot. 2000 Jun;20(2):219-22. No abstract available.

PMID:
10877267
50.

Supplemental Content

Loading ...
Support Center